JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108394

Anti-BACE1 antibody [EPR3956]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

5

(2 Reviews)

|

(84 Publications)

Anti-BACE1 antibody [EPR3956] (ab108394) is a rabbit monoclonal antibody detecting BACE1 in Western Blot, IP. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications

View Alternative Names

BACE, KIAA1149, BACE1, Beta-secretase 1, Aspartyl protease 2, Beta-site amyloid precursor protein cleaving enzyme 1, Memapsin-2, Membrane-associated aspartic protease 2, ASP2, Asp 2, Beta-site APP cleaving enzyme 1

9 Images
Immunoprecipitation - Anti-BACE1 antibody [EPR3956] (AB108394)
  • IP

Lab

Immunoprecipitation - Anti-BACE1 antibody [EPR3956] (AB108394)

ab108394 (purified) at 1/40 immunoprecipitating BACE1 in human fetal brain whole tissue lysate.

Lane 1 (input) : human fetal brain whole tissue lysate (10μg)

Lane 2 (+) : ab108394 + human fetal brain whole tissue lysate (10μg).

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108394 in human fetal brain whole tissue lysate.

For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1500 dilution.

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-BACE1 antibody [EPR3956] (ab108394)

Predicted band size: 39 kDa,56 kDa

Observed band size: 42 kDa,70 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Lab

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394) at 1/10000 dilution

All lanes:

Human fetal brain tissue lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 70 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Lab

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Western blot : Anti-BACE1 antibody [EPR3956] (ab108394) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab108394 was shown to bind specifically to BACE1. A band was observed at 56 kDa in wild-type U-87 MG cell lysates with no signal observed at this size in BACE1 knockout cell line. To generate this image, wild-type and BACE1 knockout U-87 MG cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394) at 1/1000 dilution

Lane 1:

Wild-type U-87 MG cell lysate at 20 µg

Lane 2:

Western blot - Human BACE1 knockout U-87 MG cell line (ab306623)

Lane 2:

BACE1 knockout U-87 MG cell lysate at 20 µg

Lane 3:

Wild-type SH-SY5Y cell lysate at 20 µg

Lane 4:

BACE1 knockout SH-SY5Y <a href='/en-us/products/unavailable/human-bace1-knockout-sh-sy5y-cell-line-ab280078'>ab280078</a> cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 56 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Lab

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : BACE1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : SHSY5Y whole cell lysate (20 μg)
Lane 4 : Human brain whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab108394 observed at 70 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab108394 was shown to recognize BACE1 in wild type cells as signal was lost at the expected MW in BACE1 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and BACE1 knockout samples were subjected to SDS-PAGE. ab108394 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394)

Predicted band size: 56 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Lab

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

False colour image of Western blot : Anti-BACE1 antibody [EPR3956] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab108394 was shown to bind specifically to BACE1. A band was observed at 60/70 kDa in wild-type SH-SY5Y cell lysates with no signal observed at this size in Bace1 knockout cell line ab280078 (knockout cell lysate ab280137). To generate this image, wild-type and Bace1 knockout SH-SY5Y cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

Lanes 1 - 3:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394) at 1/1000 dilution

Lanes 1 - 3:

Western blot - Anti-BACE1 antibody [EPR3956] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/bace1-antibody-epr3956-bsa-and-azide-free-ab237595'>ab237595</a>) at 1/1000 dilution

Lane 1:

Wild-type SH-SY5Y cell lysate at 20 µg

Lane 2:

Bace1 knockout SH-SY5Y cell lysate at 20 µg

Lane 2:

Western blot - Human BACE1 knockout SH-SY5Y cell line (<a href='/en-us/products/unavailable/human-bace1-knockout-sh-sy5y-cell-line-ab280078'>ab280078</a>)

Lane 2:

Western blot - Human BACE1 knockout SH-SY5Y cell lysate (ab280137)

Lane 3:

HAP1 cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680R at 1/20000 dilution

Observed band size: 70 kDa,60 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Lab

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394) at 1/10000 dilution

Lane 1:

Mouse brain tissue lysate at 20 µg

Lane 2:

Rat brain tissue lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution

Predicted band size: 56 kDa

Observed band size: 70 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

Unknown

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

All lanes:

Western blot - Anti-BACE1 antibody [EPR3956] (ab108394) at 1/1000 dilution

Lane 1:

Fetal brain lysate at 10 µg

Lane 2:

SH-SY5Y lysate at 10 µg

Lane 3:

Mouse brain lysate at 10 µg

Lane 4:

Rat brain lysate at 10 µg

Predicted band size: 56 kDa

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

CiteAb

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Western Blotting using Anti-BACE1 antibody [EPR3956], ab108394. Publication image from Yu, Q. et al., 2018, Nat Commun, 30061577. Legend direct from paper.

Effect of EP overexpression on cerebral Aβ accumulation. ELISA for measurement of Aβ40 (a, c) and Aβ42 (b, d) in the entorhinal cortex of Tg mAPP and Tg Sh3gl2/mAPP mice at the age of 5–5.5 months. EUK-134 (EUK, 2 mg/kg) (c, d) or SB203580 (SB, 0.5 mg/kg) (c, d) was administered to Tg Sh3gl2/mAPP mice once a day for 3 weeks and then cortical tissues were subjected to Aβ measurement at the age of 5–5.5 months. Date are shown as mean ± s.e.m., n = 3–6 per group (one-way ANOVA in a–d). Quantification of immunoreactive bands for Aβ (e), BACE1 (g), or IDE (i) in the indicated Tg mice at the age of 5–5.5 months. Quantification of immunoreactive bands for Aβ (f), BACE1 (h), or IDE (j) in Tg Sh3gl2.mAPP mice treated with EUK or P38 inhibitor (SB) relative to vehicle treatment. β-Actin was used as a protein loading control. Lower panels are representative immunoblots for the indicated proteins in the indicated Tg mice. Date are shown as mean ± s.e.m., n = 3 per group (one-way ANOVA in e–j)

false

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)
  • WB

CiteAb

Western blot - Anti-BACE1 antibody [EPR3956] (AB108394)

Western Blotting using Anti-BACE1 antibody [EPR3956], ab108394. Publication image from Yu, Q. et al., 2018, Nat Commun, 30061577. Legend direct from paper.

Effect of EP overexpression on cerebral Aβ accumulation. ELISA for measurement of Aβ40 (a, c) and Aβ42 (b, d) in the entorhinal cortex of Tg mAPP and Tg Sh3gl2/mAPP mice at the age of 5–5.5 months. EUK-134 (EUK, 2 mg/kg) (c, d) or SB203580 (SB, 0.5 mg/kg) (c, d) was administered to Tg Sh3gl2/mAPP mice once a day for 3 weeks and then cortical tissues were subjected to Aβ measurement at the age of 5–5.5 months. Date are shown as mean ± s.e.m., n = 3–6 per group (one-way ANOVA in a–d). Quantification of immunoreactive bands for Aβ (e), BACE1 (g), or IDE (i) in the indicated Tg mice at the age of 5–5.5 months. Quantification of immunoreactive bands for Aβ (f), BACE1 (h), or IDE (j) in Tg Sh3gl2.mAPP mice treated with EUK or P38 inhibitor (SB) relative to vehicle treatment. β-Actin was used as a protein loading control. Lower panels are representative immunoblots for the indicated proteins in the indicated Tg mice. Date are shown as mean ± s.e.m., n = 3 per group (one-way ANOVA in e–j)

false

  • Carrier free

    Anti-BACE1 antibody [EPR3956] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3956

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody shows very low cross-reactivity with BACE2.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-BACE1 antibody [EPR3956] (ab108394) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.

What is the molecular weight of BACE1?
Anti-BACE1 [EPR3956] (ab108394) specifically detects a band for BACE1 (UniProt: P56817) at a molecular weight of 56kDa.

Trusted by the scientific community
Anti-BACE1 [EPR3956] (ab108394) was first used in a scientific publication in 2011 and has been cited over 60 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-BACE1 antibody [EPR3956] (ab108394) has been confirmed by Western blot testing in BACE1 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR3956] also available for your convenience: ab108394, Carrier free - ab237595

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

BACE1 also known as beta-site APP cleaving enzyme 1 or beta-secretase plays an important role in the cleavage of amyloid precursor protein (APP). This cleavage results in the production of amyloid-beta peptides which are associated with Alzheimer's disease. BACE1 is a membrane-bound aspartic protease and has a molecular weight of approximately 50100 Da. The enzyme expresses mostly in the brain's neurons and some secretory tissues.
Biological function summary

BACE1 initiates the amyloidogenic pathway of APP processing which involves amyloid-beta generation. BACE1 doesn't function alone but acts as part of a complex that aids in protein substrate recognition and processing. Its activity contributes to physiological processes like myelination and axonal guidance indicating its importance beyond amyloid production.

Pathways

BACE1 is integral to the amyloidogenic pathway which is important in Alzheimer's disease development. It interacts with proteins such as presenilin 1 a part of the gamma-secretase complex that further processes the amyloid-beta precursor. Furthermore BACE1 links to synaptic functions and neural signaling pathways highlighting its multifaceted roles.

BACE1 holds significance in Alzheimer's disease due to its role in amyloid-beta peptide production. This connection has led to the development of BACE1 inhibitors as potential therapeutic agents. Additionally BACE1's involvement in other neural functions ties it to cognitive impairments. It also relates to APP through its function in Alzheimer's suggesting targeted strategies for treatment could involve modulating BACE1 activity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase (PubMed : 10656250, PubMed : 10677483, PubMed : 20354142). Cleaves CHL1 (By similarity).
See full target information BACE1

Publications (84)

Recent publications for all applications. Explore the full list and refine your search

Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e70580 PubMed40843775

2025

Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation.

Applications

Unspecified application

Species

Unspecified reactive species

Emma P Danhash,Anthony C Verbeck,Daniel Western,Andrea S Díaz-Pacheco,Grant Galasso,Shih-Feng You,Guangming Huang,Emma Starr,Nadia Miller,Collin J Nadarajah,Savannah Tiemann Powles,Erik S Musiek,Jasmin Herz,Abhirami K Iyer,John Cirrito,Carlos Cruchaga,Celeste M Karch

Molecular neurodegeneration 20:65 PubMed40468412

2025

The UNC5C T835M mutation associated with Alzheimer's disease leads to neurodegeneration involving oxidative stress and hippocampal atrophy in aged mice.

Applications

Unspecified application

Species

Unspecified reactive species

Devi Krishna Priya Karunakaran,Makenna Ley,Joanna Guo,Ammaarah Khatri,Katherine Sadleir,Jelena Popovic,Arun Kumar Upadhyay,Jeffrey Savas,Daniele Procissi,Jasvinder Atwal,Robert Vassar

Acta neuropathologica 149:51 PubMed40411591

2025

Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice.

Applications

Unspecified application

Species

Unspecified reactive species

Katherine R Sadleir,Karen P Gomez,Abigail E Edwards,Armana J Patel,Makenna L Ley,Ammaarah W Khatri,Joanna Guo,Shreya Mahesh,Elyse A Watkins,Jelena Popovic,Devi Krishna Priya Karunakaran,Dmitry Prokopenko,Rudolph E Tanzi,Bernabe Bustos,Steven J Lubbe,Alexis R Demonbruen,Elizabeth M McNally,Robert Vassar

Science advances 11:eadt7981 PubMed40408490

2025

Disruption of BAG3-mediated BACE1 stabilization alleviates neuropathology and memory deficits in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Xia,Junjie Li,Yayan Pang,Chunfang Dai,Mingliang Xu,Yehong Du,Qiuyun Tian,Lilin Yi,Bin Wu,Mulan Chen,Yiqiong Qiu,Chongjie Cheng,Yu Tian Wang,Weihong Song,Zhifang Dong

Neuromolecular medicine 27:34 PubMed40374872

2025

Far-Infrared Radiation Ameliorates the Cognitive Dysfunction in an Alzheimer's Disease Transgenic Mouse via Modulating Jak-2/Stat3 and Nrf-2/HO-1 Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Wen Yang,Qiuxia Yu,Nick Wang,Koon Kit Lam,Zhi-Xiu Lin,Yan-Fang Xian

Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e14402 PubMed39740209

2025

Roles of blood monocytes carrying TREM2 mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice.

Applications

Unspecified application

Species

Unspecified reactive species

Zhong-Yuan Yu,Jie Liu,Zhi-Hao Liu,Xiao-Yu Liu,Jin-Mei Tuo,Jiang-Hui Li,Yun-Feng Tu,Qi Tan,Yuan-Yuan Ma,Yu-Di Bai,Jia-Yan Xin,Shan Huang,Gui-Hua Zeng,An-Yu Shi,Jun Wang,Yu-Hui Liu,Xian-Le Bu,Li-Lin Ye,Ying Wan,Tong-Fei Liu,Xiao-Wei Chen,Zi-Long Qiu,Chang-Yue Gao,Yan-Jiang Wang

PLoS biology 22:e3002727 PubMed39042667

2024

Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Rikesh M Rajani,Robert Ellingford,Mariam Hellmuth,Samuel S Harris,Orjona S Taso,David Graykowski,Francesca Kar Wey Lam,Charles Arber,Emre Fertan,John S H Danial,Matthew Swire,Marcus Lloyd,Tatiana A Giovannucci,Mathieu Bourdenx,David Klenerman,Robert Vassar,Selina Wray,Carlo Sala Frigerio,Marc Aurel Busche

Zoological research 45:845-856 PubMed39004862

2024

SIL1 improves cognitive impairment in APP23/PS45 mice by regulating amyloid precursor protein processing and Aβ generation.

Applications

Unspecified application

Species

Unspecified reactive species

Qunxian Wang,Yanshuang Jiang,Zijun Meng,Xiangjun Dong,Dongjie Hu,Liangye Ji,Weihui Zhou,Weihong Song

International journal of molecular sciences 25: PubMed38892390

2024

Involvement of Endolysosomes and Aurora Kinase A in the Regulation of Amyloid β Protein Levels in Neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Zahra Afghah,Nabab Khan,Gaurav Datta,Peter W Halcrow,Jonathan D Geiger,Xuesong Chen

International journal of molecular sciences 25: PubMed38791263

2024

Melatonin Inhibits Hypoxia-Induced Alzheimer's Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nongnuch Singrang,Chutikorn Nopparat,Jiraporn Panmanee,Piyarat Govitrapong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com